Preferred Label : nalbuphine;
MeSH definition : A narcotic used as a pain medication. It appears to be an agonist at kappa opioid
receptors and an antagonist or partial agonist at mu opioid receptors.; A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS
and an antagonist or partial agonist at MU RECEPTORS.;
CISMeF synonym : 23277-43-2 (Nalbuphine hydrochloride); SERB brand of nalbuphine; nalbuphine SERB brand; serb, nalbuphine; hydrochloride, nalbuphine; nalbuphine serb;
MeSH hyponym : Nalbuphine Hydrochloride; nubain; EN-2234A; EN 2234A; EN2234A;
MeSH CAS label : Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5alpha,6alpha)-;
MeSH Related Number : nalbuphine hydrochloride; 20594-83-6 (Nalbuphine); 23277-43-2 (HCl); ZU4275277R;
Registry Number MeSH : 20594-83-6;
Related CAS MeSH : ZU4275277R (Nalbuphine hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Nalbuphine hydrochloride;
Codes EINECS : 243-901-6;
Is substance : O;
UNII : L2T84IQI2K;
InChIKey : NETZHAKZCGBWSS-CEDHKZHLSA-N;
Origin ID : D009266;
UMLS CUI : C0027348;
- ATC code(s)
- Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
A narcotic used as a pain medication. It appears to be an agonist at kappa opioid
receptors and an antagonist or partial agonist at mu opioid receptors.
A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS
and an antagonist or partial agonist at MU RECEPTORS.
http://www.lecrat.eu/?s=Nalbuphine
2014
false
false
false
France
French
drug information
nalbuphine
nalbuphine
---
http://www.has-sante.fr/portail/jcms/c_1735606/fr/nalbuphine-mylan
2014
France
evaluation of the transparency committee
nalbuphine
---
http://www.has-sante.fr/portail/jcms/c_1735608/fr/nalbuphine-aguettant
2014
France
evaluation of the transparency committee
nalbuphine
---
http://www.has-sante.fr/portail/jcms/c_1735637/fr/nalbuphine-renaudin
2014
France
evaluation of the transparency committee
nalbuphine
---
http://www.has-sante.fr/portail/jcms/c_1735601/fr/nalbuphine-serb
2014
France
evaluation of the transparency committee
nalbuphine
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64634871
2012
France
summary of product characteristics
package leaflet
injections
nalbuphine
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61214830
2012
France
summary of product characteristics
package leaflet
nalbuphine
injections
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68786410
2012
France
summary of product characteristics
package leaflet
nalbuphine
injections
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67816929
2012
France
summary of product characteristics
package leaflet
nalbuphine
injections
---
http://dumas.ccsd.cnrs.fr/dumas-00623593/fr/
2011
France
dissertations, academic
dystocia
analgesia, epidural
data collection
nalbuphine
---